Stratified medicine for mental disorders

Abstract

There is recognition that biomedical research into the causes of mental disorders and their treatment needs to adopt new approaches to research. Novel biomedical techniques have advanced our understanding of how the brain develops and is shaped by behaviour and environment. This has led to the advent of stratified medicine, which translates advances in basic research by targeting aetiological mechanisms underlying mental disorder. The resulting increase in diagnostic precision and targeted treatments may provide a window of opportunity to address the large public health burden, and individual suffering associated with mental disorders. While mental health and mental disorders have significant representation in the "health, demographic change and wellbeing" challenge identified in Horizon 2020, the framework programme for research and innovation of the European Commission (2014-2020), and in national funding agencies, clear advice on a potential strategy for mental health research investment is needed. The development of such a strategy is supported by the EC-funded "Roadmap for Mental Health Research" (ROAMER) which will provide recommendations for a European mental health research strategy integrating the areas of biomedicine, psychology, public health well being, research integration and structuring, and stakeholder participation. Leading experts on biomedical research on mental disorders have provided an assessment of the state of the art in core psychopathological domains, including arousal and stress regulation, affect, cognition social processes, comorbidity and pharmacotherapy. They have identified major advances and promising methods and pointed out gaps to be addressed in order to achieve the promise of a stratified medicine for mental disorders.

Neural basis of reward anticipation and its genetic determinants

“…It may facilitate the identification of causal neural mechanisms important for the identification of previously unidentified targets and repurposing of existing drugs as well as the establishment of neurobehaviorally informed end points for clinical trials (41).…”

The bipolar maze: a roadmap through translational psychopathology

“…But it is hard to foresee an alternative to the traditional phenotype of manic-depressive illness that clinicians may be able to recognize and treat. It is much more likely, thus, that future translational research looking into concepts such as 'positive valence' or 'systems for social processes' may assist in better defining the bipolar phenotype allowing for a real 'personalized or stratified medicine' (18), rather than replacing it. The ROA-MER project (Roadmap for Mental Health Research in Europe) may provide guidance on how to implement the foundation for an alternative to the US radical shift in mental health research priorities represented by RDoC, at the European level.…”

Research in child and adolescent psychiatry: a multi-disciplinary, many-faceted endeavor

“…Fortunately, a prioritization of future research needs is getting more and more attention not only from decision makers but also from research science [13,16]. Certainly, the discussion around the prioritization process should not be leaved to single groups of health care and quality researchers or decision makers, but rather should be guided by all means by research experts of the specific field from all over the world.…”